Autosomal Dominant Leukodystrophy Caused by Lamin B1 Duplications: A Clinical and Molecular Case Study of Altered Nuclear Function and Disease

被引:26
|
作者
Padiath, Quasar Saleem [1 ,2 ]
Fu, Ying-Hui [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA
[2] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA
来源
NUCLEAR MECHANICS AND GENOME REGULATION | 2010年 / 98卷
关键词
PROGRESSIVE MULTIPLE-SCLEROSIS; PELIZAEUS-MERZBACHER-DISEASE; ADULT-ONSET LEUKODYSTROPHY; GILFORD-PROGERIA-SYNDROME; AUTONOMIC SYMPTOMS; OLIGODENDROCYTE DEVELOPMENT; STRUCTURAL ORGANIZATION; PARTIAL LIPODYSTROPHY; ALEXANDER-DISEASE; A-TYPE;
D O I
10.1016/S0091-679X(10)98014-X
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Autosomal dominant leukodystrophy (ADLD) is an adult-onset demyelinating disorder that has recently shown to be caused by duplications of the nuclear lamina gene, lamin B1. This chapter attempts to collate and summarize the current knowledge about the disease and the clinical, pathological, and radiological presentations of the different ADLD families described till date. It also provides an overview of the molecular genetics underlying the disease and the mechanisms that may cause the duplication mutation event. ADLD is the first disease that has ever been linked to lamin B1 mutations and it expands the pathological role of the nuclear lamia to include disorders of the brain. The chapter also speculates on the different mechanisms that may link an important and ubiquitous structure like the nuclear lamina with the complex and cell-specific functions of myelin formation and maintenance. Understanding these mechanisms may not only prove helpful in understanding ADLD pathology but can also help in identifying new pathways that may be involved in myelin biology that can have implications for common demyelinating diseases like multiple sclerosis.
引用
收藏
页码:337 / 357
页数:21
相关论文
共 44 条
  • [31] A Study of Nuclear Factor-Kappa B1 Gene Polymorphism Types in Schizophrenia Patients and Their Correlation With Disease Severity
    Swain, Susree A.
    Sarangi, Pratikhya
    Rattan, Roma
    Sahu, Pratima K.
    Lamare, Andrew A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [32] Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease
    Meijer, Esther
    Drenth, Joost P. H.
    d'Agnolo, Hedwig
    Casteleijn, Niek F.
    de Fijter, Johan W.
    Gevers, Tom J.
    Kappert, Peter
    Peters, Dorien J. M.
    Salih, Mahdi
    Soonawala, Darius
    Spithoven, Edwin M.
    Torres, Vicente E.
    Visser, Folkert W.
    Wetzels, Jack F. M.
    Zietse, Robert
    Gansevoort, Ron T.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (03) : 446 - 455
  • [33] The clinical phenotype of late-onset autosomal dominant Alzheimer disease due to a PSEN1 mutation resembles sporadic Alzheimer disease: A single-family case-control study
    Day, Gregory
    Musiek, Erik
    Roe, Catherine
    Norton, Joanne
    Goatee, Alison
    Cruchaga, Carlos
    Morris, John
    NEUROLOGY, 2016, 86
  • [34] Electrocardiogram in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy patients without any clinical evidence of coronary artery disease - A case-control study
    Cumurciuc, R
    Henry, P
    Gobron, C
    Vicaut, E
    Bousser, MG
    Chabriat, H
    Vahedi, K
    STROKE, 2006, 37 (04) : 1100 - 1102
  • [35] Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study
    Park, Hayne Cho
    Hwang, Jin Ho
    Kang, Ah-Young
    Ro, Han
    Kim, Myung-Gyu
    An, Jung Nam
    Park, Ji In
    Kim, Seung Hyup
    Yang, Jaeseok
    Oh, Yun Kyu
    Oh, Kook-Hwan
    Noh, Jung Woo
    Cheong, Hae Il
    Hwang, Young-Hwan
    Ahn, Curie
    BMC NEPHROLOGY, 2012, 13
  • [36] Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study
    Hayne Cho Park
    Jin Ho Hwang
    Ah-Young Kang
    Han Ro
    Myung-Gyu Kim
    Jung Nam An
    Ji In Park
    Seung Hyup Kim
    Jaeseok Yang
    Yun Kyu Oh
    Kook-Hwan Oh
    Jung Woo Noh
    Hae Il Cheong
    Young-Hwan Hwang
    Curie Ahn
    BMC Nephrology, 13
  • [37] A randomized phase 1b cross-over study of the safety of low-dose pioglitazone for treatment of autosomal dominant polycystic kidney disease
    Blazer-Yost, Bonnie L.
    Bacallao, Robert L.
    Erickson, Bradley J.
    LaPradd, Michelle L.
    Edwards, Marie E.
    Sheth, Nehal
    Swinney, Kim
    Ponsler-Sipes, Kristen M.
    Moorthi, Ranjani N.
    Perkins, Susan M.
    Torres, Vicente E.
    Moe, Sharon M.
    CLINICAL KIDNEY JOURNAL, 2021, 14 (07) : 1738 - 1746
  • [38] A Novel Heterozygous and Pathogenic Variant of the HNF1B Gene Associated with Autosomal Dominant Tubulointerstitial Kidney Disease with a Broad Spectrum of Extrarenal Phenotypes: A Case Report
    Kaimori, Jun -Ya
    Matsuda, Jun
    Jan, Asif
    Kawano, Yuki
    Kawaoka, Takayuki
    Asahina, Yuta
    Doi, Yohei
    Oka, Tatsufumi
    Nagata, Miho
    Ishihara, Yasuki
    Miyashita, Yohei
    Asano, Toshihiro
    Sakaguchi, Yusuke
    Isaka, Yoshitaka
    INTERNAL MEDICINE, 2025,
  • [39] Autosomal dominant cerebellar ataxia type I. Clinical and molecular study in 36 Italian families including a comparison between SCA1 and SCA2 phenotypes
    Filla, A
    DeMichele, G
    Campanella, G
    Perretti, A
    Santoro, L
    Serlenga, L
    Ragno, M
    Calabrese, O
    Castaldo, I
    DeJoanna, G
    Cocozza, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 142 (1-2) : 140 - 147
  • [40] Heterogeneous nuclear ribonucleoprotein A2/B1 as a novel biomarker in elderly patients for the prediction of postoperative neurocognitive dysfunction: A prospective nested case-control study
    Xia, Tong
    Yang, Chenyi
    Wang, Xinyi
    Bai, Lili
    Ma, Ji
    Zhao, Mingshu
    Hua, Wei
    Wang, Haiyun
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14